Wave Life Sciences (WVE) shares rose more than 14% in recent Tuesday trading after RBC Capital Markets upgraded the stock to outperform from sector perform and raised its price target to $27 from $9.
Trading volume stood at over 23.7 million compared with a daily average of about 4.9 million.
Price: 21.16, Change: +2.64, Percent Change: +14.25